Subcutaneous vs intramuscular testosterone: what the data says

What did @alpha_tonton actually say?

Honestly? Very little that's usable. The transcript provided for this video is incoherent, referencing PayPal transfers, shoes, and South Africa rather than anything related to subcutaneous versus intramuscular testosterone injections. The caption promises a comparison of injection routes for what appears to be a TRT-related audience, but the actual spoken content doesn't deliver that. We can't fact-check claims that weren't made, so we'll use this space to address what the video claimed it would cover based on its caption and stated question.

The caption asks three specific things: what are the advantages of subcutaneous over intramuscular injection, whether they're equally effective, and whether there are risks. These are legitimate clinical questions worth answering properly, even if this video apparently didn't answer them at all.

Does the science back up the premise?

The premise, that SC and IM routes are worth comparing for testosterone administration, is well-supported. The question is no longer fringe. It's been studied directly.

A 2017 study by Spratt et al. published in the Journal of Clinical Endocrinology and Metabolism found that subcutaneous testosterone cypionate injections produced stable serum testosterone levels comparable to intramuscular administration, with less variability in peak-to-trough swings. That variability point matters clinically. Large peaks and troughs with IM injections have been associated with mood fluctuation and erythrocytosis risk in some patients.

A 2019 analysis by Kaminetsky et al. in the Journal of Drugs in Dermatology further supported SC administration as a viable route, noting patient preference for self-injection was higher with SC due to reduced injection-site discomfort. Needles used for SC are shorter and thinner, typically 27-29 gauge, compared to the 21-23 gauge needles often used for deep IM injections.

So the premise of the comparison is scientifically grounded. The video just apparently didn't get there.

What did they get wrong, or right?

There is nothing to fact-check in the actual transcript. The audio content has no relationship to the stated topic. This is a significant problem for any viewer who watched expecting clinical guidance on injection technique and instead got an incoherent monologue. That's not a minor slip. For a topic like injection administration, which carries real procedural risk if done incorrectly, uninformative content dressed up as expert guidance is a problem.

What the video got right, structurally, is asking questions that matter to TRT patients. SC versus IM is a genuinely debated topic in clinical practice. Many endocrinologists and urologists still default to IM out of habit rather than evidence, so raising the question has value. The failure is in not answering it.

• No evidence that SC is discussed or explained
• No evidence that IM risks are addressed
• No evidence that efficacy comparison was made
• Transcript content is entirely unrelated to the stated topic

What should you actually know?

If you're on TRT or considering it, here is what the actual evidence says about injection routes. SC injections into abdominal or thigh fat deposits are generally well-tolerated and produce slower, more stable absorption. This can translate to more consistent hormone levels week to week. IM injections, typically into the gluteus or vastus lateralis, are absorbed faster and can produce higher initial peaks followed by a more rapid decline.

Neither route is universally superior. Patient body composition matters, very lean individuals may have limited SC tissue. Injection frequency also matters: SC is often used with more frequent, smaller doses such as twice weekly, which helps flatten the curve further.

Risks exist with both routes. Improper SC technique can cause lipodystrophy or localized fat changes at the injection site over time. IM injections carry risk of hitting a nerve or blood vessel if technique is poor. Neither risk is common when done correctly, but neither is zero.

Always discuss route selection with a licensed prescribing clinician. FormBlends providers can assess which approach fits your specific protocol and body composition.